BSc, BVSc, MRCVS, Diplomate ACVIM (Oncology) Diplomate ACVR (Radiation Oncology)back to Doctors + Staff
Molecular Targeted Medical Therapy, Immunotherapy, 3D Targeted Radiation Therapy, Palliative Therapy, Antiangiogenesis
Faculty of Veterinary Science, University of Pretoria, Onderstepoort, Republic of South Africa
Animal Medical Center, NYC
The Ohio State University
- American Veterinary Medical Association (AVMA)
- Southern California Veterinary Medical Association (SCVMA)
- Veterinary Cancer Society
- American Animal Hospital Association (AAHA)
- Veterinary Cooperative Oncology Group (VCOG)
- Veterinary Radiation Therapy Oncology Group: Co-Chair (VRTOG)
- Pfizer ELITE Oncology Group
- Medical Advisory Board of the Los Angeles Zoo
- California Veterinary Medical Association (CVMA)
- Santa Barbara Ventura Veterinary Medical Association (SBVVMA)
BSc, BVSc, MRCVS, Diplomate ACVIM (Oncology) Diplomate ACVR (Radiation Oncology)
Born and raised in Zimbabwe, Dr. Rodney Ayl graduated in 1985 from the Faculty of Veterinary Science, University of Pretoria, Onderstepoort, Republic of South Africa.
After graduation he practiced large animal work in Zimbabwe for a short time before his arrival in the United States. Dr. Ayl worked in a mixed animal practice in upstate New York, before going to the Animal Medical Center in New York City, where he completed an internship in small animal medicine and surgery. After the internship, Dr. Ayl moved to Columbus, Ohio where he began his Medical Oncology Residency program at The Ohio State University. In 1994, Dr Ayl passed the Board Certification examination of the American College of Veterinary Internal Medicine in the Specialty of Oncology and in 2000, Dr. Ayl was grandfathered in, and Certified by, the American College of Radiology, in the Specialty of Radiation Oncology.
Dr. Ayl has provided medical and radiation oncology services in the Southern California area since 1991, and has lectured internationally as well as locally in various topics on cancer treatment in domestic animals. He was also part of the Animal Specialty Group team for 13 years – from 1993-2006.
He sits on the Medical Advisory Board of the LA Zoo, and has provided consultation services to veterinarians through regional reference laboratories. He has, and does presently participate in clinical trials for the development of new treatment options for people and their pets. He has authored and co-authored numerous articles on oncologic topics in peer reviewed journals and reference books.
As a double-Boarded medical and radiation oncologist, Dr. Ayl’s main area of interest is the utilization of surgery, chemotherapy, radiation, immunotherapy and gene therapy in the development of multi-modality therapy protocols to optimize the treatment options and outcomes for people and their pets. He works with a Grief Support Group, to make sure that all aspects of a client’s concerns and experiences, associated with their pet’s cancer diagnosis and treatment, are addressed.
Dr. Ayl has served on the Public Relations Committees of both the Southern California Veterinary Medical Association and the American College of Veterinary Internal Medicine in order to help make Veterinarians, and their clients, aware of what specialty veterinary services have to offer them. Dr. Ayl is a member of the Veterinary Cancer Society, Veterinary Cooperative Oncology Group and the Veterinary Radiation Therapy Oncology Group, which are dedicated to the principle of research and the dissemination of information on cooperative clinical trials and other studies, to improve the survival and lives of animals with cancer.
- Heart-Base Tumor with Pericardial Effusion & Cardiac Tamponade
- Lymphoma in Dogs: A Basic Overview of What It Is and What You Need to Know.
- Cancer Therapy Handbook. Couto CG et al. 1992. Radiographic Education Systems. Ayl RD, Editor & Co-author.
- Unexpected neurotoxicity in dogs receiving a cyclophosphamide, dactinomycin, and 5-fluorouracil chemotherapy protocol. Hammer AS, Carothers MA, Harris CL, O’Keefe DA, Ayl RD, Peterson JL, Shank KA, Couto CG. J Vet Intern Med. 1994 May-Jun;8(3):240-3.
- Treatment of tumor-bearing dogs with actinomycin D. Hammer AS, Couto CG, Ayl RD, Shank KA. J Vet Intern Med. 1994 May-Jun;8(3):236-9.
- Acute sterile hemorrhagic cystitis after a single intravenous administration of cyclophosphamide in three dogs. Peterson JL, Couto CG, Hammer AS, Ayl RD. J Am Vet Med Assoc. 1992 Nov 15;201(10):1572-4.
- Parathyroid hormone (PTH)-related protein, PTH, and 1,25-dihydroxyvitamin D in dogs with cancer-associated hypercalcemia. Rosol TJ, Nagode LA, Couto CG, Hammer AS, Chew DJ Peterson JL, Ayl RD, Steinmeyer CL, Capen CC. Endocrinology. 1992 Sep;131(3):1157-64.
- Correlation of DNA ploidy to tumor histologic grade, clinical variables, and survival in dogs with mast cell tumors. Ayl RD, Couto CG, Hammer AS, Weisbrode S, Ericson JG, Mathes L. Vet Pathol. 1992 Sep;29(5):386-90.
- Effects of mithramycin on calcium metabolism and bone in dogs. Rosol TJ, Chew DJ, Couto CG, Ayl RD, Nagode LA, Capen CC. Vet Pathol. 1992 May;29 (3):223-9.
Lectures + Presentations
- 2002 – Present: Regular lectures to Interns and Referring Veterinarians on various cancer topics.
- 1992 – Present: Regular monthly lectures on different cancer topics, to different chapters of the Southern California Veterinary Medical Association, the California Veterinary Medical Association, the Santa Barbara Ventura Veterinary Medical Association and the San Diego Veterinary Medical Association.
- 1995 Cancer Therapy in Animals. School of Veterinary Medicine, Bet Dagon, Israel.
- 1992 Cancer Therapy in Animals. Faculty of Veterinary Science, Pretoria, RSA.
back to Doctors + Staff